\\client\x$\products\raloxifene Hydrochloride Tabs Anda 078193\submissions\2016-03-18 Cbe-0 (AJK\Working\INSERT\Image File\raloxifene-structure01.jpg)
Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 71335-1715
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 71335-1715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
\\client\x$\products\raloxifene Hydrochloride Tabs Anda 078193\submissions\2016-03-18 Cbe-0 (AJK\Working\INSERT\Image File\raloxifene-figure01.JPG)
Total hip mean percentage changes from baseline were measured over 24 months in subjects taking either Allplacebo and raloxifene hydrochloride or CE (conjugated estrogens) in Studies A, EU, and INT (in hysterectomized women). The data was analyzed through a latent intent to treat analysis and using certain observation criteria. The results show that raloxifene hydrochloride had a positive effect on the percentage change in total hip mean.*
Label (Lbl713351715)
This is a medication package label for Raloxifene 60mg tablets. The tablets are white and oval-shaped, with the imprint "7290;93". The label contains instructions for storage at room temperature and a warning to keep the medication out of reach of children. The package also includes information on the product code, batch number, expiration date, and NDC number.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
